Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 110Head and Neck Neoplasms 97Nasopharyngeal Carcinoma 36Carcinoma, Non-Small-Cell Lung 21Salivary Gland Neoplasms 17Carcinoma, Squamous Cell 14Laryngeal Neoplasms 12Nasopharyngeal Neoplasms 10Melanoma 10Breast Neoplasms 10Oropharyngeal Neoplasms 9Hypopharyngeal Neoplasms 9Stomach Neoplasms 8Neoplasms 8Esthesioneuroblastoma, Olfactory 8Esophageal Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 7Carcinoma, Renal Cell 7Urinary Bladder Neoplasms 6Tongue Neoplasms 6Small Cell Lung Carcinoma 6Recurrence 6Lung Neoplasms 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Mouth Neoplasms 4

Interventions

toripalimab 1Radiotherapy 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Docetaxel × Head & Neck × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡